4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035691
Director returned 3,300 shares (to the company)
- Director acquired 3,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fust Matthew K Director | 2023-06-07 | Grant or award | +3,860 | 30,355 | D: show line 1 in the form | ||
| Fust Matthew K Director | 2023-06-07 | Returned to the company | −3,300 | $51.82 | $171,006 | 27,055 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fust Matthew K Director | 2023-06-07 | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | D: show line 3 in the form |
Loading xslF345X04/doc4.xml…